Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BraineHealth is a Swedish digital health company focused on AI-powered diagnostic decision support for healthcare. Its core product, Diagnosio, is presented as a patented AI diagnostics platform and "virtual doctor" building block intended to help patients and clinicians assess symptoms, prioritize next diagnostic steps, and improve triage in primary care and related settings. The company markets its technology as based on U.S. Patent 11,908,579 B2 and describes applications across healthcare, including primary care and diabetes-related use cases. BraineHealth appears to operate primarily as a private healthcare AI and diagnostics platform company rather than a traditional therapeutics developer, with licensing and partnership activity emphasized over a drug pipeline. The company is headquartered in Norrtälje, Sweden.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BraineHealth.